Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The Supreme Court will hear a challenge to Obamacare’s preventive care mandates, giving Trump a chance to reshape rules on ...

Regeneron Pharmaceuticals Inc.'s executives and board members overstated its key eye treatment’s average selling price, ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

DBS Group Research believes that healthcare businesses operating in Johor could be primary beneficiaries of the ...

The No7 Line Correcting Booster Serum, currently reduced from £34.95 to £27.96 at Boots, is a dermatologist-approved and science-backed product that's clinically proven to reduce the appearance of ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Providing nutritional support to half the households with individuals undergoing tuberculosis (TB) treatment could prevent ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

"Shoppers can hop straight into Easter at Aldi by stocking up on the delicious Specially Selected Luxury Fruited Hot Cross ...